查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2033161

血漿衍生產品市場規模、佔有率、趨勢和預測：按類型、應用、最終用戶和地區分類，2026-2034 年

Blood Plasma Derivatives Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2025年全球血漿衍生產品市場規模為508億美元。展望未來，IMARC Group預測，該市場將以4.76%的複合年成長率從2026年成長至2034年，到2034年達到781億美元。目前，北美在該市場佔據主導地位，預計2025年市佔率將超過48.9%。慢性病盛行率上升、先進的血漿採集基礎設施、技術創新、人口老化以及治療應用範圍的擴大是推動該地區市場成長的部分因素。

血漿衍生產品是指透過分餾過程從血漿中製備的特定蛋白質濃縮物。常見的血漿衍生產品包括因子VIII、免疫球蛋白、白蛋白、高免疫球蛋白、因子IX和新鮮冷凍血漿。這些產品富含蛋白質、礦物質、鹽類、荷爾蒙、維生素和蛋白酶抑制劑，由於其特性，被廣泛用於去活化引起B型肝炎、甲型血友病、出血性疾病、免疫力缺乏、丙型肝炎、低丙種球蛋白血症、乙型血友病和人類免疫力缺乏病毒（HIV）感染的病毒。此外，血漿衍生產品還有助於改善營養狀況、調節體溫和血液凝固、維持滲透壓、增強呼吸和排泄功能以及調節酸鹼平衡。血漿衍生產品通常儲存在醫院、診所、診斷中心和輸血中心。

血漿衍生產品市場趨勢：

人口老化加劇，老年人更容易感染疾病，為市場帶來了良好的前景。血漿中含有免疫球蛋白，在免疫形成和維持血管內滲透壓方面發揮著至關重要的作用，從而有助於預防免疫不全症和血友病的發生。此外，康復者血漿療法在新冠肺炎患者感染疾病中的應用日益廣泛，也推動了市場成長。同時，用於分離血漿蛋白濃縮物和各種血漿成分的分離技術創新，也顯著促進了市場成長。相應地，先進的保存方法以及用於標靶治療的封裝過程的顯著改進，也進一步推動了市場成長。此外，醫療保健產業的蓬勃發展、人們對捐血和血漿的認知不斷提高，以及政府為促進捐血宣傳活動採取的各項措施，預計也將進一步推動市場成長。

市場區隔:

本報告分析了全球血漿衍生產品市場各細分領域的關鍵趨勢，並對2026年至2034年進行了全球、區域和國家層面的預測。市場按類型、應用程式和最終用戶進行細分。

按類型細分：

  • 白蛋白
  • 因子 VIII
  • 因子九
  • 免疫球蛋白
  • 高免疫球蛋白
  • 其他

按用途細分：

  • 血友病
  • 低丙種球蛋白血症
  • 免疫力缺乏
  • 血管性血友病
  • 其他

按最終用戶細分：

  • 醫院
  • 診所
  • 其他

按地區分類：

  • 北美洲
  • 我們
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

競爭格局：

關於該產業的競爭格局，我們檢視了以下主要公司概況：百特國際、拜耳股份公司、CSL有限公司、Fusion Healthcare Private Limited、Griffols SA、Kedrion SpA、LFB SA、Octa Pharma AG、賽諾菲 SA 和檢驗藥品工業株式會社。

本報告解答的主要問題

1. 什麼是血漿衍生產品？

2. 血漿衍生產品市場規模有多大？

3. 2026 年至 2034 年全球血漿衍生產品市場的預期成長率為何？

4. 全球血漿衍生產品市場的主要促進因素是什麼？

5. 全球血漿衍生物市場按類型分類的主要細分市場有哪些？

6. 從應用領域來看，全球血漿衍生產品市場中最大的細分市場是什麼？

7. 從終端用戶的角度來看，全球血漿衍生物市場的主要細分市場有哪些？

8. 全球血漿衍生產品市場的主要區域有哪些？

9. 全球血漿衍生產品市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球血漿衍生產品市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 白蛋白
  • 因子 VIII
  • 因子9
  • 免疫球蛋白
  • 高免疫球蛋白
  • 其他

第7章 市場區隔：依應用領域分類

  • 血友病
  • 低丙種球蛋白血症
  • 免疫不全症
  • 血管性血友病
  • 其他

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 診所
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Baxter International Inc.
    • Bayer AG
    • CSL Limited
    • Fusion Health Care Pvt. Ltd.
    • Grifols SA
    • Kedrion SpA
    • LFB SA
    • Octapharma AG
    • Sanofi SA
    • Takeda Pharmaceutical Company Limited
Product Code: SR112026A5371

The global blood plasma derivatives market size was valued at USD 50.8 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 78.1 Billion by 2034, exhibiting a CAGR of 4.76% from 2026-2034. North America currently dominates the market, holding a market share of over 48.9% in 2025. The rising chronic disease prevalence, advanced plasma collection infrastructure, technological innovations, growing geriatric population, and expanding therapeutic applications are some of the factors driving the market growth in this region.

Blood plasma derivatives are concentrates of specific proteins prepared from plasma that are obtained through fractionation process. Factor VIII, immunoglobulin, albumin, hyperimmune globulin, factor IX and fresh frozen are some of the common blood plasma derivatives. They are rich in proteins, minerals, salts, hormones, vitamins and protease inhibitors, due to which they are widely used to kill viruses that cause hepatitis B, hemophilia A, bleeding disorders, immunodeficiency, hepatitis C, hypogammaglobulinemia, hemophilia B and human immunodeficiency virus (HIV). Apart from this, blood plasma derivatives assist in enhancing nutrition, controlling body temperature and coagulation of blood, maintaining osmotic pressure, enhancing respiration and excretion, and regulating acid-base balance. Blood plasma derivatives are commonly stored at hospitals, clinics, diagnostic centers and blood transfusion centers.

Blood Plasma Derivatives Market Trends:

The increasing geriatric population that are more susceptible to developing infectious diseases are creating a positive outlook for the market. Blood plasma contains immunoglobulins that play an important role in the development of immunity and maintain the osmotic pressure in blood vessels, which further prevents the onset immunodeficiency disorders and hemophilia. Moreover, the widespread product adoption to treat coronavirus disease (COVID-19) patients by convalescent plasma treatment is favoring the market growth. Additionally, various technological innovations in the fractionation process that aids in separating protein concentrates and various components of blood plasma for clinical purposes are providing a considerable boost to the market growth. In line with this, the development of advanced preservation methods, along with the significant improvements in encased procedures for developing targeted therapeutic products are further augmenting the market growth. Other factors, including significant growth in the healthcare industry, increasing awareness regarding blood and plasma donation and the implementation of various government initiatives to promote blood donation camps, are anticipated to drive the market further toward growth.

Market Segmentation:

This report provides an analysis of the key trends in each segment of the global blood plasma derivatives market, along with forecast at the global, regional, and country levels from 2026-2034. The market has been categorized based on type, application, and end user.

Breakup by Type:

  • Albumin
  • Factor VIII
  • Factor IX
  • Immunoglobulin
  • Hyperimmune Globulin
  • Others

Breakup by Application:

  • Hemophilia
  • Hypogammaglobulinemia
  • Immunodeficiency Diseases
  • Von Willebrand's Disease
  • Others

Breakup by End User:

  • Hospitals
  • Clinics
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited.

Key Questions Answered in This Report

1. What are blood plasma derivatives?

2. How big is the blood plasma derivatives market?

3. What is the expected growth rate of the global blood plasma derivatives market during 2026-2034?

4. What are the key factors driving the global blood plasma derivatives market?

5. What is the leading segment of the global blood plasma derivatives market based on type?

6. What is the leading segment of the global blood plasma derivatives market based on application?

7. What is the leading segment of the global blood plasma derivatives market based on end user?

8. What are the key regions in the global blood plasma derivatives market?

9. Who are the key players/companies in the global blood plasma derivatives market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Blood Plasma Derivatives Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Albumin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Factor VIII
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Factor IX
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Immunoglobulin
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Hyperimmune Globulin
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Hemophilia
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hypogammaglobulinemia
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immunodeficiency Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Von Willebrand's Disease
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bayer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 CSL Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Fusion Health Care Pvt. Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Grifols S.A.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Kedrion S.p.A.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 LFB S.A.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Octapharma AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Sanofi S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Takeda Pharmaceutical Company Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Blood Plasma Derivatives Market: Major Drivers and Challenges
  • Figure 2: Global: Blood Plasma Derivatives Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Blood Plasma Derivatives Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Blood Plasma Derivatives Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Blood Plasma Derivatives Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Blood Plasma Derivatives Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Blood Plasma Derivatives Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Blood Plasma Derivatives (Albumin) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Blood Plasma Derivatives (Albumin) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Blood Plasma Derivatives (Factor VIII) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Blood Plasma Derivatives (Factor VIII) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Blood Plasma Derivatives (Factor IX) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Blood Plasma Derivatives (Factor IX) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Blood Plasma Derivatives (Immunoglobulin) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Blood Plasma Derivatives (Immunoglobulin) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Blood Plasma Derivatives (Other Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Blood Plasma Derivatives (Other Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Blood Plasma Derivatives (Hemophilia) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Blood Plasma Derivatives (Hemophilia) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Blood Plasma Derivatives (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Blood Plasma Derivatives (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Blood Plasma Derivatives (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Blood Plasma Derivatives (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Blood Plasma Derivatives (Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Blood Plasma Derivatives (Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Blood Plasma Derivatives (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Blood Plasma Derivatives (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: North America: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: North America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: United States: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: United States: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Canada: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Canada: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Asia-Pacific: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Asia-Pacific: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: China: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: China: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Japan: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Japan: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: India: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: India: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: South Korea: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: South Korea: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Australia: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Australia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Indonesia: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Indonesia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Others: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Europe: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Europe: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Germany: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Germany: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: France: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: France: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: United Kingdom: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: United Kingdom: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Italy: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Italy: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Spain: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Spain: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Russia: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Russia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Latin America: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Latin America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Brazil: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Brazil: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Mexico: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Mexico: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Others: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Middle East and Africa: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Middle East and Africa: Blood Plasma Derivatives Market: Breakup by Country (in %), 2025
  • Figure 84: Middle East and Africa: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Global: Blood Plasma Derivatives Industry: SWOT Analysis
  • Figure 86: Global: Blood Plasma Derivatives Industry: Value Chain Analysis
  • Figure 87: Global: Blood Plasma Derivatives Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Blood Plasma Derivatives Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Blood Plasma Derivatives Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Blood Plasma Derivatives Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Blood Plasma Derivatives Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Blood Plasma Derivatives Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Blood Plasma Derivatives Market: Competitive Structure
  • Table 7: Global: Blood Plasma Derivatives Market: Key Players